Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Particle-mediated delivery of frataxin plasmid to a human sensory neuronal model of Friedreich's ataxia

Increasing frataxin protein levels through gene therapy is envisaged to improve therapeutic outcomes for patients with Friedreich's ataxia (FRDA). A non-viral strategy that uses submicrometer-sized multilayered particles to deliver frataxin-encoding plasmid DNA affords up to 27 000-fold increase in frataxin gene expression within 2 days in vitro in a stem cell-derived neuronal model of FRDA.

Read the entire article HERE

SHARE

FacebookTwitterLinkedInYoutube
shandra1.jpg

 

Archived in
  Scientific News


 

 

Tagged in
FARA Scientific News


Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator